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MST1 gene(1)
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A protein kinase of the STE20 family.                                  
Alternative names:
Serin Threonin Kinase 4 ; STK4
Kinase Responsuve To Stress 2; KRS2
MST1(STK4), MST2(STK3)
MST kinases subgroups           
MST3(STK24), MST4(STK26),YSK(STK25)
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MST1gene(1)
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Chromosomal Location : 20q11.2-q13.2
Disease: T-cell Immunodeficiency, Recurrent Infections, And 
Autoimmunity with or without Cardiac Malformations (TIIAC) caused 
by mutations affecting the gene
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Classification(2)
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MST kinase family
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MST1 kinases 
 Emerging as key signaling molecules that influence:
cell proliferation, organ size, cell migration, and cell polarity
 Studies in this field are focuse on:
regulation and function of these kinases in normal
physiology and pathologies, including cancer, endothelial
malformations, and autoimmune disease(2)
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MST1 activation 
Apoptotic signals as well 
as other stress signals
Both phosphorilation and 
caspase-mediated 
cleavage
Dimerization
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Schematic representation of MST1 kinase.
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Two residues (Thr183 and Thr187) within the MST1 activation 
loop are essential for kinase activation(3)
Presented by Fariba Karimian - Dec 2015
MST1 activation through Raassf and simultaneous removal of negative 
regulation by Raf-1(2)
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The role of MST1 in apoptosis(4)
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The role of MST1 in hemoestasis,wound healing 
and cancer(2)
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Hippo signaling components(5)
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Amphiregulin
BIRC5
cIAP1
CTGF
Cyclin D1
Galpha s
Galpha 12/13
Lats1/2
Mob1
Mst1/2
Rho A
Sav1
TEADs
Yap/Taz
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Hippo signaling pathway(6)
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Hippo signaling regulation(7)
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The Hippo pathway mediates the reciprocal regulation of cell proliferation by contact inhibition and mitogenic
signaling
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MST1 and cancer
 In order to importance affects of  MST1/Lats signaling 
pathway on cell proliferation,it seems that these kinases
has an important role in cancers pathology
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MST1 and cancer
 Hippo-Lats-Yorkie signaling regulates tissue overgrowth 
and tumorigenesis inDrosophila. 
 Mst1 and Mst2 protein kinases;the mammalian Hippo 
orthologs.
 Mst1/2 inhibition of Yap1 is an important pathway for 
tumor suppression in human HCC.(9)
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MST1 and pathologeis
 Loss of MST1 made mouse susceptible to
autoimmune diseases including skin lesions around
eyes along with enlarged spleen
 The occurance of the SNPs on MST1 are related to
Crohn disease and colitis(10)
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Prostate Cancer
 Prostate cancer has become a major public health problem in 
Western industrialized countries.
 Most prostate cancers are very slow growing, but some can grow and 
spread quickly
 If the cancer is discovered before it spreads beyond the prostate 
gland it is potentially curable
 Prostate cancer is usually found during a routine physical 
examination (11)
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Signs & symptoms(11)
In the early stages, there may be no symptoms
As men age, the prostate can become enlarged for a number of reasons
These symptoms don’t mean that cancer is present:
 starting or stopping urination is a problem
 slow stream
 painful urination or ejaculation
 dribbling
 frequent urination
 loss of urinary control
 blood in urine or ejaculate
 night-time voiding
In advanced cases of prostate cancer, symptoms can include:
1. Weight lose
2. Fatigue
3. Backache or sciatica-like pain, or swelling of the legs that doesn’t go away
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Cancer
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PSA level(12)
 Many cases today are detected by PSA levels in the 
2.5±10 ng/ml range and are confirmed by histology of 
biopsies
 Typically, tumours were advanced and extended beyond 
the organ capsule or had metastasized. In such cases, PSA 
levels are much higher than 10 ng/ml.
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Bone metastases 
in advanced prostate 
cancer
diagram of sites often 
affected.
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Diagnosis(13)
 Nowadays, an increasing number of prostate cancers are 
detected through elevated serum PSA levels.
 Before PSA assays became routine, many cases were 
recognized by digital rectal examination (DRE).
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Diagnosis
Digital rectal examination (DRE)
PSA blood test – measures the levels of prostate specific 
antigen.
TRUS
Tissue biopsy
TURP
Bone Scan,MRI,CT
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Treatment(14)
 To aid in treatment decisions, nomograms have been 
introduced, which combine information from
digital rectal examination,
biopsy histology  
PSA assays
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Future aspects
 We are intrested in finding the relevance between this
cancer and reduced level of MST1 gene expression to
might be achieving this gene as biomarker for early
detection of prostate cancer in future researches
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